Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Excelerate Energy, Inc.EE · Entity 3984 | Director | March 05, 2026 | March 09, 2026 |
| Ingredion IncINGR · Entity 3745 | Director | September 29, 2023 | October 03, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Excelerate Energy, Inc.
Report date March 05, 2026 · Filed March 09, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 32,322 |
Reported balance
After 2026-03-05 transaction · row 1
1 source rowRow 1 · 2026-03-05 · Grant · Acquired 3,639 · Balance 32,322 F1: Represents restricted stock units ("RSUs"), each of which represents the right to receive one share of Class A common stock of the Issuer. The RSUs vest in full on the first anniversary of the grant date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents restricted stock units ("RSUs"), each of which represents the right to receive one share of Class A common stock of the Issuer. The RSUs vest in full on the first anniversary of the grant date.
Ingredion Inc
Report date September 29, 2023 · Filed October 03, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 60,438.9499 |
Reported balance
After 2023-09-29 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2023-09-29 · Grant · Acquired 627.573 · Balance 60,438.9499 F1: These are restricted stock units issued to the Company's outside directors as part of their annual retainer and are payable in stock no earlier than six months after resignation or retirement as a director and no later than ten years thereafter. F2: Includes restricted stock units ("RSUs") acquired through deemed dividend reinvestment. RSUs acquired through deemed dividend reinvestment vest on the dates when the RSU's with respect to which they are deemed dividends vest. F3: These shares are held direct by a third party private partner. |
Filing footnotes · ownership attribution and instrument terms
F1: These are restricted stock units issued to the Company's outside directors as part of their annual retainer and are payable in stock no earlier than six months after resignation or retirement as a director and no later than ten years thereafter.
F2: Includes restricted stock units ("RSUs") acquired through deemed dividend reinvestment. RSUs acquired through deemed dividend reinvestment vest on the dates when the RSU's with respect to which they are deemed dividends vest.
F3: These shares are held direct by a third party private partner.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
AquaVenture Holdings Ltd
Report date March 30, 2020 · Filed March 30, 2020
Section 16 reporting ended · disclosed 2020-03-30. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary SharesSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2020-03-30 transaction · row 1
1 source rowRow 1 · 2020-03-30 · Disposition to issuer · Disposed 22,837 · Balance 0 F1: Pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated as of December 23, 2019, among Culligan International Company, a Delaware corporation ("Parent"), Amberjack Merger Sub Limited, a business company incorporated under the laws of the British Virgin Islands and a subsidiary of Parent ("Merger Sub"), and the Issuer, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent (the "Merger"). At the effective time of the Merger, each ordinary share outstanding, automatically and without any required action on the part of the Reporting Person, was converted into the right to receive $27.10 in cash, without interest. |
| Share OptionsSEC Table II · derivative / convertible security · Conversion / exercise price $18.00 | Direct | 0 |
Reported balance
After 2020-03-30 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2020-03-30 · Disposition to issuer · Disposed 11,654 · Balance 0 F2: Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent. At the effective time of the Merger, each share option outstanding, whether vested or unvested, automatically and without any required action on the part of the Reporting Person, was cancelled in exchange for the right to receive an amount in cash (without interest and subject to deduction for any applicable tax withholdings) equal to the excess, if any, of $27.10 over the per share exercise price of such share option. |
| Deferred Compensation - Phantom Share UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2020-03-30 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2020-03-30 · Disposition to issuer · Disposed 18,358.03 · Balance 0 F3: Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent. At the effective time of the Merger, each phantom share unit outstanding, whether vested or unvested, automatically and without any required action on the part of the Reporting Person, became fully vested and was cancelled in exchange for a right to receive a cash payment in an amount equal to $27.10, without interest, for each ordinary share underlying the phantom share unit, less any required withholding taxes. F4: This amount includes 9,245 phantom share units that were originally reported on a Form 4 as restricted share units. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to an Agreement and Plan of Merger (the "Merger Agreement"), dated as of December 23, 2019, among Culligan International Company, a Delaware corporation ("Parent"), Amberjack Merger Sub Limited, a business company incorporated under the laws of the British Virgin Islands and a subsidiary of Parent ("Merger Sub"), and the Issuer, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent (the "Merger"). At the effective time of the Merger, each ordinary share outstanding, automatically and without any required action on the part of the Reporting Person, was converted into the right to receive $27.10 in cash, without interest.
F2: Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent. At the effective time of the Merger, each share option outstanding, whether vested or unvested, automatically and without any required action on the part of the Reporting Person, was cancelled in exchange for the right to receive an amount in cash (without interest and subject to deduction for any applicable tax withholdings) equal to the excess, if any, of $27.10 over the per share exercise price of such share option.
F3: Pursuant to the Merger Agreement, Merger Sub merged with and into the Issuer on March 30, 2020, with the Issuer surviving as a wholly-owned subsidiary of Parent. At the effective time of the Merger, each phantom share unit outstanding, whether vested or unvested, automatically and without any required action on the part of the Reporting Person, became fully vested and was cancelled in exchange for a right to receive a cash payment in an amount equal to $27.10, without interest, for each ordinary share underlying the phantom share unit, less any required withholding taxes.
F4: This amount includes 9,245 phantom share units that were originally reported on a Form 4 as restricted share units.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 02, 2018 Filed Jan 3, 2018 17:46 UTC | AquaVenture Holdings Ltd WAAS · Entity 150170 | GrantDeferred Compensation - Phantom Share Unit · Derivative | 913.04 | $16.10 | $14,699.94 |
DisclosureSEC source: 0001179110-18-000383 · edgar.xml · derivative · entry 2 HANRAHAN PAUL T · CIK 0001237644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 913.04 Underlying: Ordinary Shares · 913.04 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom share unit (which is in the form of a deferred compensation share unit) is the economic equivalent of one ordinary share of the Issuer. F2 · shares: Represents the number of phantom share units credited to the reporting person's deferred account pursuant to the Issuer's Independent Directors' Deferred Compensation Program (the "Program") which was established under the Issuer's 2016 Share Option and Incentive Plan (the "Plan"). The number of whole and fractional phantom share units credited to the reporting person's deferred account is equal to 120% of the aggregate deferred cash fees that would otherwise be payable on such date divided by the closing price of the Issuer's ordinary shares on the award date. F3 · derivative.exercise_date: Whole and fractional phantom share units credited to the reporting person's deferred account shall be settled in ordinary shares and cash, respectively, upon the earlier of the reporting person's death, disability, separation from the board, sale event (as defined in the Plan) or December 31, 2019. F3 · derivative.expiration_date: Whole and fractional phantom share units credited to the reporting person's deferred account shall be settled in ordinary shares and cash, respectively, upon the earlier of the reporting person's death, disability, separation from the board, sale event (as defined in the Plan) or December 31, 2019. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 16:58 UTC | AquaVenture Holdings Ltd WAAS · Entity 150170 | GrantDeferred Compensation - Phantom Share Unit · Derivative | 1,084.87 | $13.55 | $14,699.99 |
DisclosureSEC source: 0001179110-17-012982 · edgar.xml · derivative · entry 2 HANRAHAN PAUL T · CIK 0001237644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,035.71 Underlying: Ordinary Shares · 1,084.87 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom share unit (which is in the form of a deferred compensation share unit) is the economic equivalent of one ordinary share of the Issuer. F2 · shares: Represents the number of phantom share units credited to the reporting person's deferred account pursuant to the Issuer's Independent Directors' Deferred Compensation Program (the "Program") which was established under the Issuer's 2016 Share Option and Incentive Plan (the "Plan"). The number of whole and fractional phantom share units credited to the reporting person's deferred account is equal to 120% of the aggregate deferred cash fees that would otherwise be payable on such date divided by the closing price of the Issuer's ordinary shares on the award date. F3 · derivative.exercise_date: Whole and fractional phantom share units credited to the reporting person's deferred account shall be settled in ordinary shares and cash, respectively, upon the earlier of the reporting person's death, disability, separation from the board, sale event (as defined in the Plan) or December 31, 2018. F3 · derivative.expiration_date: Whole and fractional phantom share units credited to the reporting person's deferred account shall be settled in ordinary shares and cash, respectively, upon the earlier of the reporting person's death, disability, separation from the board, sale event (as defined in the Plan) or December 31, 2018. Read SEC document |
| October 02, 2017 Filed Oct 4, 2017 18:22 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 435.179 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-029117 · form4.xml · nonDerivative · entry 1 HANRAHAN PAUL T · CIK 0001237644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,685.6783 F1 · shares: These are restricted stock units issued to the Company's outside directors as part of their annual retainer and are payable in stock no earlier than six months after resignation or retirement as a director and no later than ten years thereafter. F2 · balance_after: Includes restricted stock units acquired through deemed dividend reinvestment. Read SEC document |
| July 03, 2017 Filed Jul 5, 2017 23:23 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 420.1193 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-023133 · form4.xml · nonDerivative · entry 1 HANRAHAN PAUL T · CIK 0001237644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,096.8671 F1 · shares: These are restricted stock units issued to the Company's outside directors as part of their annual retainer and are payable in stock no earlier than six months after resignation or retirement as a director and no later than ten years thereafter. F2 · balance_after: Includes restricted stock units acquired through deemed dividend reinvestment. Read SEC document |
| July 03, 2017 Filed Jul 6, 2017 16:56 UTC | AquaVenture Holdings Ltd WAAS · Entity 150170 | GrantDeferred Compensation - Phantom Share Unit · Derivative | 950.84 | $15.46 | $14,699.99 |
DisclosureSEC source: 0001179110-17-010181 · edgar.xml · derivative · entry 2 HANRAHAN PAUL T · CIK 0001237644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 950.84 Underlying: Ordinary Shares · 950.84 shares Expires not disclosed F1 · derivative.exercise_price: Each phantom share unit (which is in the form of a deferred compensation share unit) is the economic equivalent of one ordinary share of the Issuer. F2 · shares: Represents the number of phantom share units credited to the reporting person's deferred account pursuant to the Issuer's Independent Directors' Deferred Compensation Program (the "Program") which was established under the Issuer's 2016 Share Option and Incentive Plan (the "Plan"). The number of whole and fractional phantom share units credited to the reporting person's deferred account is equal to 120% of the aggregate deferred cash fees that would otherwise be payable on such date divided by the closing price of the Issuer's ordinary shares on the award date. F3 · derivative.exercise_date: Whole and fractional phantom share units credited to the reporting person's deferred account shall be settled in ordinary shares and cash, respectively, upon the earlier of the reporting person's death, disability, separation from the board, sale event (as defined in the Plan) or December 31, 2018. F3 · derivative.expiration_date: Whole and fractional phantom share units credited to the reporting person's deferred account shall be settled in ordinary shares and cash, respectively, upon the earlier of the reporting person's death, disability, separation from the board, sale event (as defined in the Plan) or December 31, 2018. Read SEC document |
| April 10, 2017 Filed Apr 11, 2017 16:25 UTC | AquaVenture Holdings Ltd WAAS · Entity 150170 | GrantRestricted Share Units · Derivative | 9,754 | $0.00 | $0.00 |
DisclosureSEC source: 0001179110-17-005935 · edgar.xml · derivative · entry 2 HANRAHAN PAUL T · CIK 0001237644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,754 Underlying: Ordinary Shares · 9,754 shares Expires not disclosed F1 · derivative.exercise_price: Each Restricted Share Unit represents a contingent right to receive one Ordinary Share of the Company. F2 · derivative.exercise_date: The Restricted Share Units were issued pursuant to the Company's 2016 Share Option and Incentive Plan. 100% of the shares shall vest on April 10, 2018. F2 · derivative.expiration_date: The Restricted Share Units were issued pursuant to the Company's 2016 Share Option and Incentive Plan. 100% of the shares shall vest on April 10, 2018. Read SEC document |
| April 03, 2017 Filed Apr 6, 2017 00:24 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 477.4558 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-014398 · form4.xml · nonDerivative · entry 1 HANRAHAN PAUL T · CIK 0001237644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,525.0006 F1 · shares: These are restricted stock units issued to the Company's outside directors as part of their annual retainer and are payable in stock no earlier than six months after resignation or retirement as a director and no later than ten years thereafter. F2 · balance_after: Includes restricted stock units acquired through deemed dividend reinvestment. Read SEC document |
| January 03, 2017 Filed Jan 5, 2017 23:49 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 460.1472 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-001179 · form4.xml · nonDerivative · entry 1 HANRAHAN PAUL T · CIK 0001237644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,905.5901 F1 · shares: These are restricted stock units issued to the Company's outside directors as part of their annual retainer and are payable in stock no earlier than six months after resignation or retirement as a director and no later than ten years thereafter. F2 · balance_after: Includes restricted stock units acquired through deemed dividend reinvestment. Read SEC document |
| December 28, 2016 Filed Feb 8, 2017 02:34 UTC | Ingredion Inc INGR · Entity 3745 | GiftCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-004471 · form5.xml · nonDerivative · entry 1 HANRAHAN PAUL T · CIK 0001237644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,445.4429 F1 · shares: These shares were gifted to The Altinure Foundation, Inc., a family foundation established by Paul and Rodanthe Hanrahan. F2 · balance_after: Includes restricted stock units acquired through deemed dividend reinvestment. Read SEC document |
| October 12, 2016 Filed Oct 13, 2016 16:42 UTC | AquaVenture Holdings Ltd WAAS · Entity 150170 | PurchaseOrdinary Shares | 5,560 | $18.00 | $100,080.00 |
DisclosureSEC source: 0001179110-16-030682 · edgar.xml · nonDerivative · entry 1 HANRAHAN PAUL T · CIK 0001237644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,114 F1 · shares: These shares were purchased through a directed share program in connection with the initial public offering of AquaVenture Holdings Limited. Read SEC document |
| October 03, 2016 Filed Oct 5, 2016 20:04 UTC | Ingredion Inc INGR · Entity 3745 | GrantCommon Stock | 225.4622 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-16-064306 · form4.xml · nonDerivative · entry 1 HANRAHAN PAUL T · CIK 0001237644 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,307.5486 F1 · shares: These are restricted stock units issued to the Company's outside directors as part of their annual retainer and are payable in stock no earlier than six months after resignation or retirement as a director and no later than ten years thereafter. F2 · balance_after: Includes restricted stock units acquired through deemed dividend reinvestment. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.